UKRI - Nucleic acid medicines manufacture receives £4.5m in funding

Five projects will receive funding to develop and commercialise innovative solutions for the manufacturing of nucleic acid medicines. Innovate UK announces today the winners of a funding competition to create and bring to market inventive approaches while enhancing the resource effectiveness, output and expandability for producing nucleic acid medications. Published on the 09th of May 2024. Find the entire news report here.

Publication Details

Journal: Industrias Culturais (Universidade de Coimbra)
Published: 2024-11-04
DOI: https://doi.org/10.58079/12m6t
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

UKRI - Nucleic acid medicines manufacture receives £4.5m in funding

Nov 4, 2024

Industrias Culturais (Universidade de Coimbra)

CAR-T cell therapy research

article

UKRI - Nucleic acid medicines manufacture receives £4.5m in funding

November 4, 2024article en

Abstract

Industrias Culturais (Universidade de Coimbra)

Industry, innovation and infrastructure

Openalex Percentile: Top 55%

CAR-T cell therapy research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

UKRI - Nucleic acid medicines manufacture receives £4.5m in funding · Industrias Culturais (Universidade de Coimbra) (2024) | TGRS Research Map | TGRS